WPRIM Management System> DCMS> Journal of Gynecologic Oncology> 2009> 20

Volume: 20

1. Book Review: New Theory and Technique for Nerve-Sparing Radical Hysterectomy. Page:260—260
2. A favorable maternal and neonatal outcome following chemotherapy with etoposide, bleomycin, and cisplatin for management of grade 3 immature teratoma of the ovary. Page:257—259
3. Pregnancy following vulvar squamous cell carcinoma: a report of two cases. Page:254—256
4. A case of advanced gynecologic pelvic tumors showing the diagnostic utility of HPV analysis. Page:251—253
5. Chemotherapy and patient co-morbidity in ventral site hernia development. Page:246—250
6. Epstein-Barr virus-transformation of B-cell lines in ovarian cancer patients: feasibility of genomic storage for unlimited use. Page:243—245
7. A hospital-based case-control study of identifying ovarian cancer using symptom index. Page:238—242
8. Atlas of procedures in Laparoscopic Hysterectomy. Page:134—134
9. In reply. Page:133—133
10. Differing prognosis of cervical cancer patients with high risk of treatment failure after radical hysterectomy: To the editor. Page:132—132
11. Metastatic carcinoma of cervix mimicking psoas abscess on imaging: a case report. Page:129—131
12. A case of mucinous adenocarcinoma arising from retroperitoneal teratoma treated with chemoradiation. Page:126—128
13. A case of multiple metastatic low-grade endometrial stromal sarcoma arising from an ovarian endometriotic lesion. Page:122—125
14. Expression and mutational analysis of TGF-beta/Smads signaling in human cervical cancers. Page:117—121
15. TRAIL-induced cell death and caspase-8 activation are inhibited by cisplatin but not carboplatin. Page:113—116
16. Surgical practice patterns in endometrial cancer: results of the Korean Gynecologic Oncology Group survey. Page:107—112
17. Prognostic factors of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer. Page:101—106
18. Efficacy of taxane and platinum-based chemotherapy guided by extreme drug resistance assay in patients with epithelial ovarian cancer. Page:96—100
19. Factors associated with HPV persistence after conization in patients with negative margins. Page:91—95
20. Role of high risk-human papilloma virus test in the follow-up of patients who underwent conization of the cervix for cervical intraepithelial neoplasia. Page:86—90
21. ASCO's 45th Annual Meeting, May 29-June 2, 2009. Page:84—85
22. Epidemiologic report of gynecologic cancer in Thailand. Page:81—83
23. Current status of gynecological cancer care in India. Page:77—80
24. Current status of gynecological cancer in China. Page:72—76
25. Current status of gynecologic cancer in Japan. Page:67—71
26. Asian Society of Gynecologic Oncology (ASGO): a central platform against gynecologic cancers in Asia. Page:65—66
27. The utility of the human papillomavirus DNA load for the diagnosis and prediction of persistent vaginal intraepithelial neoplasia. Page:232—237
28. Treatment outcomes and prognostic factors in uterine cervical cancer patients treated with postoperative extended field radiation therapy. Page:227—231
29. Weekly cisplatin or gemcitabine concomitant with radiation in the management of locally advanced carcinoma cervix: results from an observational study. Page:221—226
30. Correlation between tumor volume response to radiotherapy and expression of biological markers in patients with cervical squamous cell carcinoma. Page:215—220
31. KGOG's & KSGOC's Symposium, Nov. 12-13, 2009. Page:213—214
32. ASGO's First Biennial Meeting, Nov. 22, 2009. Page:210—212
33. Major clinical research advances in gynecologic cancer 2009. Page:203—209
34. Time for global efforts with clinical trials for advanced cervical cancer patients. Page:201—202
35. Comparative study of neoadjuvant chemotherapy before radical hysterectomy and radical surgery alone in stage IB2-IIA bulky cervical cancer. Page:22—27
36. Differing prognosis of cervical cancer patients with high risk of treatment failure after radical hysterectomy warrants trial treatment modification. Page:17—21
37. Epidemiology, prevention and treatment of cervical cancer in the Philippines. Page:11—16
38. Gynecological cancer in Indonesia. Page:8—10
39. Current status of cervical cancer and HPV infection in Korea. Page:1—7
40. Vaginal evisceration after radical hysterectomy and adjuvant radiation. Page:63—64
41. A case of clear cell carcinoma arising from the endometriosis of the paraovarian cyst. Page:60—62
42. Postoperative acute renal failure in patients with gynecologic malignancies: analysis of 10 cases and review of the literature. Page:55—59
43. Synergistic growth inhibition by combination of adenovirus mediated p53 transfer and cisplatin in ovarian cancer cell lines. Page:48—54
44. Fertility preservation in patients with early epithelial ovarian cancer. Page:44—47
45. Association between bacterial vaginosis and cervical intraepithelial neoplasia. Page:39—43
46. The accuracy of cervical cancer and cervical intraepithelial neoplasia diagnosis with loop electrosurgical excisional procedure under colposcopic vision. Page:35—38
47. Comparison of concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil versus cisplatin plus paclitaxel in patients with locally advanced cervical carcinoma. Page:28—34
48. ERRATUM: Role of high risk-human papilloma virus test in the follow-up of patients who underwent conization of the cervix for cervical intraepithelial neoplasia. Page:200—200
49. In reply: Different role of secondary cytoreductive surgery by surgeon's experience and hospital facility. Page:199—199
50. Prognostic factors of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer. Page:198—198
51. A single horn endometrial carcinoma of a uterus bicornis unicollis. Page:195—197
52. A case of non-gestational choriocarcinoma arising in the ovary of a postmenopausal woman. Page:192—194
53. A case of neutrophilia related to a cytokine-producing relapsed squamous cell carcinoma of the uterine cervix arising from the rectovaginal septum. Page:187—191
54. Premenopausal early-stage endometrial carcinoma patients with low CA-125 levels and low tumor grade may undergo ovary-saving surgery. Page:181—186
55. Clinical analysis of intra-operative frozen section proven borderline tumors of the ovary. Page:176—180
56. Correlation between preoperative serum levels of five biomarkers and relationships between these biomarkers and cancer stage in epithelial overian cancer. Page:169—175
57. Treatment of the patients with abnormal cervical cytology: a "see-and-treat" versus three-step strategy. Page:164—168
58. Prognostic factors in adult granulosa cell tumors of the ovary: a retrospective analysis of 80 cases. Page:158—163
59. Acute toxicity of cyclooxygenase-2 inhibitor rofecoxib as a radiosensitizer for concurrent chemoradiation in the treatment of uterine cervical cancer. Page:151—157
60. Prognostic significance of neutropenia during adjuvant concurrent chemoradiotherapy in early cervical cancer. Page:146—150
61. JSGO's 46th Biannual Meeting, July 10-12, 2009. Page:145—145
62. Recent advances of robotic surgery and single port laparoscopy in gynecologic oncology. Page:137—144
63. International Federation of Gynecology and Obstetrics (FIGO) staging system revised: what should be considered critically for gynecologic cancer?. Page:135—136